Phase 3, open-label trial of lenalidomide and low-dose dexamethasone with or without pembrolizumab (MK-3475) in newly diagnosed, treatment-naïve multiple myeloma who are ineligible for autologous stem cell transplant - Regional Cancer Care Associates LLC

Clinical Trials

Phase 3, open-label trial of lenalidomide and low-dose dexamethasone with or without pembrolizumab (MK-3475) in newly diagnosed, treatment-naïve multiple myeloma who are ineligible for autologous stem cell transplant

Type of Cancer
Multiple Myeloma
Locations
East Brunswick
Freehold
Howell
Little Silver
Sparta
Sponsor
MERCK
Protocol Number
MERCK-3475-185
Cancer Diagnosis
To Learn More Call
201-510-0910